1. European Medicines Agency. Infanrix hexa – EPAR: product information [Internet]. Amsterdam (EU): European Medicines Agency; [updated 2020 Oct 15; cited 2021 Jun 18]. Available from: https://www.ema.europa.eu/en/documents/product-information/infanrix-hexa-epar-product-information_en.pdf
2. European Medicines Agency. Hexyon – EPAR: product information [Internet]. Amsterdam (EU): European Medicines Agency; [updated 2021 Mar 25; cited 2021 Jun 18]. Available from: https://www.ema.europa.eu/en/documents/product-information/hexyon-epar-product-information_en.pdf
3. European Medicines Agency. Vaxelis – EPAR: product information [Internet]. Amsterdam (EU): European Medicines Agency; [updated 2020 Dec 1; cited 2021 Jun 18]. Available from: https://www.ema.europa.eu/en/documents/product-information/vaxelis-epar-product-information_en.pdf
4. European Medicines Agency (EMA). Hexavac - withdrawal of marketing authorisation in the European Union. 2012 [cited 2020 Oct 05]. https://www.ema.europa.eu/en/documents/public-statement/public-statement-hexavac-withdrawalmarketing-authorisation-european-union_en.pdf;